All Title Author
Keywords Abstract


Chronic obstructive pulmonary disease as a cardiovascular risk factor: results of a case-control study (CONSISTE study)

DOI: http://dx.doi.org/10.2147/COPD.S40706

Keywords: Chronic obstructive pulmonary disease as a cardiovascular risk factor: results of a case-control study (CONSISTE study) Letter (905) Total Article Views Authors: Falola M Published Date February 2013 Volume 2013:8 Pages 105 - 106 DOI: http://dx.doi.org/10.2147/COPD.S40706 Received: 25 November 2012 Accepted: 03 January 2013 Published: 21 February 2013 Michael Falola Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA I read with interest the article "Chronic obst

Full-Text   Cite this paper   Add to My Lib

Abstract:

Chronic obstructive pulmonary disease as a cardiovascular risk factor: results of a case-control study (CONSISTE study) Letter (905) Total Article Views Authors: Falola M Published Date February 2013 Volume 2013:8 Pages 105 - 106 DOI: http://dx.doi.org/10.2147/COPD.S40706 Received: 25 November 2012 Accepted: 03 January 2013 Published: 21 February 2013 Michael Falola Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA I read with interest the article "Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study)" by de Lucas-Ramos et al.1 In my opinion, the study did not use case-control design, despite its title. View original paper by de Lucas-Ramos and colleagues. Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case–control study (CONSISTE study) The search for common pathways underlying asthma and COPD Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol Supplemental vitamin D and physical performance in COPD: a pilot randomized trial Short communication: carboxylate functionalized superparamagnetic iron oxide nanoparticles (SPION) for the reduction of S. aureus growth post biofilm formation Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis noncontact ultra-widefield module versus the Optos Optomap Optimizing safety of COPD treatments: role of the nurse practitioner Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry

Full-Text

comments powered by Disqus